Results from Upadacitinib Phase 3 SELECT-MONOTHERAPY Study Published in The Lancet - PharmiWeb.com

Results from Upadacitinib Phase 3 SELECT-MONOTHERAPY Study Published in The Lancet  PharmiWeb.com

Maidenhead, 28 May, 2019 — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the publication of positive results from the pivotal ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases